OXYCODONE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxycodone Hydrochloride, and when can generic versions of Oxycodone Hydrochloride launch?
Oxycodone Hydrochloride is a drug marketed by Ani Pharms, Avanthi Inc, Dr Reddys Labs Sa, Genus Lifesciences, Lannett Co Inc, Novel Labs Inc, Abhai Llc, Alkem Labs Ltd, Ascent Pharms Inc, Aurolife Pharma Llc, Chartwell Molecular, Hikma, Pharm Assoc, Pharmobedient Cnsltg, Quagen, Rhodes Pharms, Specgx Llc, Vistapharm, Wes Pharma Inc, Actavis Elizabeth, Alvogen, Amneal Pharms, Epic Pharma Llc, Nesher Pharms, Nuvo Pharm, Strides Pharma, Sun Pharm Inds Inc, Vintage Pharms, Barr Labs Inc, and Watson Labs. and is included in fifty-one NDAs.
The generic ingredient in OXYCODONE HYDROCHLORIDE is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.
Summary for OXYCODONE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 30 |
NDAs: | 51 |
Finished Product Suppliers / Packagers: | 37 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Clinical Trials: | 563 |
Patent Applications: | 2,337 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for OXYCODONE HYDROCHLORIDE |
What excipients (inactive ingredients) are in OXYCODONE HYDROCHLORIDE? | OXYCODONE HYDROCHLORIDE excipients list |
DailyMed Link: | OXYCODONE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for OXYCODONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Center for Complementary and Integrative Health (NCCIH) | Early Phase 1 |
Washington State University | Early Phase 1 |
University of Miami | Phase 2 |
Pharmacology for OXYCODONE HYDROCHLORIDE
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for OXYCODONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for OXYCODONE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
OXAYDO | Tablets | oxycodone hydrochloride | 5 mg and 7.5 mg | 202080 | 1 | 2012-02-07 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 20 mg | 022272 | 2 | 2010-10-29 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 15 mg | 022272 | 1 | 2010-10-28 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 10 mg | 022272 | 1 | 2010-10-25 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 30 mg, 60 mg and 80 mg | 022272 | 1 | 2010-10-18 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 40 mg | 022272 | 1 | 2010-10-04 |
US Patents and Regulatory Information for OXYCODONE HYDROCHLORIDE
OXYCODONE HYDROCHLORIDE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting OXYCODONE HYDROCHLORIDE
ADDITIONAL CLINICAL TRIAL INFORMATION ADDED TO PEDIATRIC USE SUBSECTION
Exclusivity Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nesher Pharms | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 077290-001 | Dec 8, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Strides Pharma | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 077712-002 | Jan 31, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alvogen | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 202116-001 | Dec 30, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |